MUFG Securities EMEA’s AstraZeneca AZN Stock Holding History

MUFG Securities EMEA’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222M	Buy	1,186,481 +322,501	+37%	+$60.7M	2.33%	8
2026 Q1	$168M	Buy	+863,980	New	+$167M	2.5%	7

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MUFG Securities EMEA's AZN Position: Q2 2026 in Review

MUFG Securities EMEA increased its AstraZeneca (AZN) stake by 37% in Q2 2026, buying an estimated $60.7M and bringing the position to 1,186,481 shares worth $222M. The position accounts for 2.33% of the portfolio, ranked #8.

MUFG Securities EMEA first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

MUFG Securities EMEA held 1,186,481 shares of AstraZeneca worth $222M as of Q2 2026.
MUFG Securities EMEA bought 322,501 AstraZeneca shares in Q2 2026, an estimated $60.7M.
AstraZeneca made up 2.33% of MUFG Securities EMEA's portfolio in Q2 2026, its #8 holding.
MUFG Securities EMEA first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.